EUVIMEDEUVIMED entdecken
Crossref

Evaluating the Clomiphene Citrate versus Letrozole among infertile patients

Maram Salah M. Khalil, Elmahaishi MS, Hungarian Board

American Journal of Medical and Clinical Research & Reviews · 2026 · 05 (07) · 1-10

DOI: 10.58372/2835-6276.1409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical and Clinical Research & Reviews, 2026. Verfasst von Maram Salah M. Khalil und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infertility, defined as the inability to conceive after 12 months of unprotected intercourse in women under 35 years or after 6 months in women aged 35 years or older, affects 8–12% of women worldwide. Clomiphene citrate, a selective estrogen receptor modulator, and letrozole, an aromatase inhibitor, are widely used agents for ovarian stimulation.

Objective

To compare the effectiveness of clomiphene citrate and letrozole in infertile women at Lamis Infertility Center, Misurata, Libya.

Methods

A randomized controlled trial was conducted at Lamis Infertility Center, Misurata, Libya, between January and December 2025. Two hundred infertile women were randomly assigned to receive either clomiphene citrate (n=100) or letrozole (n=100). Clinical data were collected and analyzed to assess treatment outcomes with IBM SPSS v24.

Results

The mean age of participants was 34.2 ± 7.8 years. Primary and secondary infertility were equally represented (50% each), with unexplained infertility accounting for 81% of cases. Ovarian hyperstimulation occurred in 8% overall (10% in the letrozole group vs. 6% in the clomiphene group). Pregnancy was achieved in 86% of cases (172/200), with a significantly higher rate in the letrozole group (94/100, 94%) compared to the clomiphene citrate group (78/100, 78%) (p = 0.021).

Conclusion

Letrozole demonstrated superior pregnancy outcomes compared to clomiphene citrate, although with a slightly increased risk of ovarian hyperstimulation in women with polycystic ovarian syndrome. Age, infertility type, and unexplained infertility influenced treatment response. Letrozole may be considered a preferred option for enhancing pregnancy rates in infertile women.

Zitieren

APA

Khalil, M. S. M., MS, E., & Board, H. (2026). Evaluating the Clomiphene Citrate versus Letrozole among infertile patients. American Journal of Medical and Clinical Research & Reviews, 05(07), 1-10. https://doi.org/10.58372/2835-6276.1409

Vancouver

Khalil MSM, MS E, Board H. Evaluating the Clomiphene Citrate versus Letrozole among infertile patients. American Journal of Medical and Clinical Research & Reviews. 2026;05(07):1-10. doi:10.58372/2835-6276.1409

BibTeX
@article{Khalil2026,
  author = {Khalil, Maram Salah M. and MS, Elmahaishi and Board, Hungarian},
  title = {Evaluating the Clomiphene Citrate versus Letrozole among infertile patients},
  journal = {American Journal of Medical and Clinical Research & Reviews},
  year = {2026},
  volume = {05},
  number = {07},
  pages = {1--10},
  doi = {10.58372/2835-6276.1409}
}
Kostenlos starten →